Analytical Data
-
基因名
fimG
- Application
-
种属
Escherichia coli
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P08190
-
表达区间
24-167aa
-
分子量
22.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FimG is a vital protein associated with the type 1 fimbriae of uropathogenic Escherichia coli (UPEC), which plays a crucial role in bacterial adhesion to the urinary tract, contributing to urinary tract infections (UTIs). This protein is encoded by the fimbrial operon and is essential for the assembly and stability of fimbrial structures. Research into FimG is significant due to the rising incidence of antibiotic-resistant infections, highlighting the need for alternative therapeutic targets. Understanding the molecular mechanisms underlying FimG's function can aid in the development of new strategies to inhibit bacterial adhesion, thereby preventing UTI recurrence. Furthermore, structural studies of FimG may provide insights into its interactions with other fimbrial components and host tissues. Given the public health implications of UTIs and the challenges posed by multidrug-resistant bacteria, the investigation of FimG and its role in UPEC pathogenesis represents a promising area of research that could lead to innovative treatment approaches and enhance our understanding of bacterial virulence factors.
